Clinical Trial Update: FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating fluorodopa (FDOPA) PET/MRI for pre-operative evaluation of gliomas; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Malignant Glioma

Drugs mentioned

• Fluorodopa (FDOPA) (6-[18F]fluoro-L-DOPA)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioma, Malignant Glioma | Phase 1 | Status: TERMINATED